Parent company Quarterhill is still undergoing a strategic review to determine whether to sell WiLAN, but doesn’t want the delay to remind anyone of the stagnant BlackBerry patent sale
The company has scrapped its failed $600 million deal with Catapult IP Innovations and now will seek US and Canadian government regulatory approval to close a $200 million pact
Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it
Battle of two once-notable smartphone brands emerges in Shenzhen, with one pivoting to patent licensing and another seeking to stage a commercial comeback
22 March 2022
Deal announced by French pharma giant this week is highly distinctive, but also reflects several recent trends in the booming drug revenue market
17 March 2022
Reports suggest the companies are engaged in a patent licensing dispute as they re-negotiate a previous deal to include 5G coverage
16 March 2022
In a familiar story, LG is set to exit another major operating segment in which it owns some of the strongest patent holdings
15 March 2022
A recent deal shows that a wider selection of corporates are exploring acquisition opportunities and working with custom R&D labs
08 March 2022
Arbutus Biopharma and Genevant Sciences have filed suit against the vaccine innovator
07 March 2022
Chief IP counsel must know how to use recent Federal Circuit precedent to draft non-disclosure agreements that either allow or block future IPRs based on their business needs
04 March 2022
Survey of deals forms part of wider IAM Q1 2022 Special Report on patent transactions now available to subscribers
03 March 2022
ROI’s latest report on sales activity and reflections on 10 years of market tracking
02 March 2022
Some of the highest-value deals in intellectual property today are taking place in the burgeoning marketplace for revenue streams linked to pharmaceutical products
02 March 2022
Unlock unlimited access to all IAM content
